BioSpace News Archive

Press Releases

Bio-Rad to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025

April 15, 2025
·
1 min read
Press Releases

Century Therapeutics to Host Live Fireside Chat Focused on Newly Prioritized Preclinical Cell Therapy Programs for Autoimmune Diseases and Cancer on Tuesday, April 22, 2025

April 15, 2025
·
5 min read
Press Releases

Charles River Laboratories Schedules First-Quarter 2025 Earnings Release and Conference Call

April 15, 2025
·
1 min read
Press Releases

Radiance Announces First Patient Dosing in Phase 1 Clinical Trial of its Next Generation ROR-1 Targeted ADC for Hematologic and Solid Malignancies

April 15, 2025
·
2 min read
Press Releases

Orthofix to Report First Quarter 2025 Financial Results

April 15, 2025
·
1 min read
Press Releases

Toragen, Inc. Provides Update on Phase 1 Clinical Trial of TGN-S11 as Monotherapy and in Combination with Keytruda® in Patients with Stage 4 HPV-Associated Cancers

April 15, 2025
·
3 min read
Press Releases

Imperative Care Announces Independent Randomized Clinical Trial for Treatment of M2 Occlusions in Stroke Patients

April 15, 2025
·
3 min read
Press Releases

Pilatus Biosciences to Present Research on PLT012 at AACR 2025

April 15, 2025
·
3 min read
Press Releases

Sarepta Therapeutics Announces Pipeline Progress for Multiple Limb-Girdle Muscular Dystrophy Programs

April 15, 2025
·
8 min read
Press Releases

Lyell Immunopharma Receives Regenerative Medicine Advanced Therapy (RMAT) Designation for LYL314 for the Treatment of Relapsed and/or Refractory Large B-Cell Lymphoma

April 15, 2025
·
8 min read